Case Submissions

Call for Cases

The ISSVA Debates & Updates 2025 Call for Cases is now closed. Case submission notifications are scheduled to go out mid-January 2025.  

Debates & Updates Meeting Dynamics
Below is a list of the topics for the presentations. The moderators will be encouraging a debate style presentation. Thus have your cases support one issue and defend it with evidence or real time data. All presentations will be 4 minutes, followed by a 5-minute discussion. Be prepared for lively participation!

Call for Cases and Case Series topics we were seeking included:

• Medical Treatment
  • Agents, single or combined therapy, short- and long-term side effects, treatment on or off study, study endpoints and measurement of effectiveness
• Coagulation Disorders
  • What patients are at risk? What is the evidence? Who needs to be tested?
  • What is evidence for therapy? What is the best therapy?
  • When should these treatments be used? IR procedures? Surgery? For pain?
  • What are the risks of treatment?
• Slow Flow Malformation 
  • Focus on certain Diagnoses: intra muscular venous malformations, FAVA, Vascular malformations involving the knee, foot, or other joints
  • Topics: Surgery vs. IR, cryotherapy, risk to the joint, when is aggressive therapy needed? Other available therapies, QOL issues, cost effectiveness, medical therapy
  • Patient Stories
• Fast Flow Lesion Sessions
  • Focus: Head and Neck AVM, Foot AVM, High flow lesions mimicking AVM (PHOST) others
  • Topics: compare treatment options (IR, Surgical, medical, combined), when is enough...enough? Cost effectiveness, QOL
  • Patient Stories
• Bone lesions (venous, lymphatic)
  • Topics:  When to treat? How to treat? How do we measure response?
• Clinical Follow-up and Observation
  • Is there still a place for this?
  • Patient Stories
• Visceral/bone Vascular Anomalies (Hepatic, vertebral/bone, spleen, kidney)
  •  Pathology
  • Genomics
  • How should these lesions be defined? What is their natural history?
  • Patient Stories
• Multidisciplinary Vascular Anomaly Centers
  • Is there a right way to build this?
• Patient advocacy and family support groups
  • What are their worries and concerns?
  • How are they best included in our meeting structure?